首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Endothelial and smooth muscle cell populations in a decellularized cryopreserved aortic homograft (SynerGraft) 2 years after implantation.
【24h】

Endothelial and smooth muscle cell populations in a decellularized cryopreserved aortic homograft (SynerGraft) 2 years after implantation.

机译:植入后2年,去细胞的冷冻保存的主动脉同种异体移植物(SynerGraft)中的内皮细胞和平滑肌细胞群体。

获取原文
获取原文并翻译 | 示例
       

摘要

While the cryopreserved homograft heart valve is an established option for patients requiring replacement of damaged or diseased aortic valves, there is evidence that valve durability may be negatively impacted by the allogenicity of residual viable cells.1 Decellularization techniques, like the SynerGraft process, reduce the cellular content of homograft valves, in hopes of modifying the host immune response to the graft. Uncertainty remains over the mechanism and extent of "recellularization" occurring in these decellularized grafts after implantation in humans. Characterization of cells populating the implanted decellularized grafts is important in understanding host adaptation and possibly in-vivo longevity of the grafts. This report details the histomorphologic and immunophenotypic features of cells identified in a decellularized (SynerGraft) aortic valve recovered two years after implantation.
机译:尽管冷冻保存的同种异体心脏瓣膜是需要更换受损或患病主动脉瓣膜的患者的既定选择,但有证据表明,瓣膜的耐用性可能会受到残余活细胞异体性的负面影响。1脱细胞技术,例如SynerGraft工艺,可减少同种异体瓣膜的细胞含量,希望改变宿主对移植物的免疫反应。植入人体后,在这些脱细胞的移植物中发生的“重新细胞化”的机制和程度仍不确定。组成植入的脱细胞移植物的细胞的表征对于理解宿主适应性以及移植物的体内寿命很重要。该报告详细介绍了在植入两年后恢复的脱细胞主动脉瓣(SynerGraft)中鉴定出的细胞的组织形态学和免疫表型特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号